Avrobio | 营业费用

Operating Expenses 更改 日
Adcock Ingram Holdings ZAR 3.91B 168.42M 2023-06
Alnylam Pharmaceuticals USD 537.77M 18.35M 2024-03
Celltrion KRW 73.04B 294.4B 2024-03
Cspc Pharmaceutical CNY 5.8B 34.94M 2023-12
Dianthus Therapeutics USD 18.72M 5.3M 2024-03
Ecofibre AUD 19.41M 20.67M 2023-06
Gilead Sciences USD 6.88B 1.37B 2024-03
Ionis Pharmaceuticals USD 269.01M 34.82M 2024-03
Kangmei Pharma CNY 1.26B 82.83M 2024-03
Knight Therapeutics CAD 83.94M 707K 2024-03
Laboratorios Farma EUR 131.89M 181.99M 2024-03
MacroGenics USD 62.85M 2.78M 2024-03
Malin Corporation EUR 2.2M 800K 2023-06
Medical Developments International AUD 29.84M 359K 2023-06
Neuren Pharmaceuticals AUD 14.78M 6.84M 2023-06
Organigram Holdings CAD 52.6M 221K 2024-03
Pfizer USD 10.68B 10.12B 2024-03
Pharma Mar EUR 42.3M 3.33M 2024-03
Probiotec AUD 99.23M 4.08K 2023-06
Qiagen NV USD 360.55M 38M 2024-03
Roche Holding CHF 20.02B 5.04B 2023-06
Sanofi EUR 8.89B 600M 2024-03
Sarepta Therapeutics USD 378.56M 1.6M 2024-03
Sartorius EUR 697.2M 32.6M 2024-03
Sino Biopharmaceutical CNY 11.53B 892.53M 2023-06
Takeda JPY 1.01T 86.16B 2023-12
Tilray USD 221.71M 13.82M 2024-02
Zz Pientze Pharmaceu 1.52B 25.23M 2023-09



Avrobio 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.